Novel composition preventing or treating hepatitis C through control of viral RNA polymerase phosphorylation
@inproceedings{2011NovelCP,
title={Novel composition preventing or treating hepatitis C through control of viral RNA polymerase phosphorylation},
author={오종원},
year={2011}
}The present invention not only can prevent or treat as, more particularly, Hepatitis C through a novel PRK2 inhibitors dig through the structure modeled on the composition of a new hepatitis C prevention or treatment for controlling the replication enzyme phosphorylation by administration of an Hsp90 inhibitor combination can effectively prevent or treat hepatitis C, and particularly interferon non-sensitivity C-type hepatitis.